市場調查報告書
商品編碼
1261342
2022-2028 年全球足踝器械市場規模,份額,行業趨勢分析報告展望和預測(按應用,產品,地區劃分)Global Foot and Ankle Devices Market Size, Share & Industry Trends Analysis Report By Application, By Product, By Regional Outlook and Forecast, 2022 - 2028 |
足踝器械市場規模預計將在 2028 年達到 61 億美元,預測期內復合年增長率為 7.1%。
類風濕性關節炎 (RA) 影響全世界大約 1% 的人,據說女性受影響的頻率是男性的兩倍多。 據世界衛生組織 (WHO) 稱,據信有超過 2300 萬人患有類風濕性關節炎。 然而,RA 患者目前接受的醫療保健無法滿足未來預期的經濟負擔。 據專家稱,到 2030 年,患有 RA 的人數可能會翻一番。 這被認為是由於嬰兒潮一代年齡組的轉變,專家對 RA 的更好理解以及 70 歲及以上人群 RA 發病率略高等因素所致。
此外,據信全世界有超過 2 億人患有骨質疏鬆症。 根據國際骨質疏鬆基金會的最新數據,在 50 歲以上的人群中,三分之一的女性和五分之一的男性一生中會發生骨質疏鬆性骨折。 此外,骨質疏鬆症不僅會縮短預期壽命,還會延長傷殘調整後的預期壽命,給負責其治療的每個國家的醫療保險系統帶來巨大的財政負擔。 因此,足部和腳踝裝置的市場有望迅速擴大。
COVID-19 影響分析
在大流行期間,腳踝外傷患者的數量顯著減少。 結果,隨著醫院轉向應對 COVID-19 流行病,對足部和腳踝設備的需求減少了。 骨科專業人員因無法專注於日常患者而深受其害。 治療 COVID-19 患者需要重新部署醫護人員。 醫院員工和運營基礎設施的缺乏減緩了市場擴張。 COVID-19 大流行嚴重影響了足部和腳踝設備市場,因為供應鏈受到限制,這些設備的分銷受到阻礙,全球範圍內的治療也有所減少。
市場增長因素
足部和腳踝問題在全球範圍內呈上升趨勢
類風濕性關節炎,骨關節炎和創傷後關節炎是通常影響腳和腳踝的三大關節炎。 使用矯形器,例如踝關節矯形器 (AFO),可以提高運動成績。 此外,使用支具和特殊結構的支具可以減輕疼痛,減輕足部的負擔。 與普通產品相比,諸如提高療效,降低成本,患者舒適度和使用方便等優勢將增加對這些設備的需求,從而有利於腳踝設備市場。
增加技術和戰略舉措的採用
此外,患者數量,手術專業知識以及中國等國家也是重要指標。 3D 打印骨科設備領域的特點是包括由鈷鉻合金,不銹鋼和 ALPHA-BETA 鈦合金 (Ti-6Al-4V) 製成的個體假體和金屬植入物。 因此,市場進入者的戰略舉措和設備製造領域對先進技術的日益接受正在推動市場的擴張。
市場製約因素
足踝裝置的嚴重副作用
長時間使用牙套會導致韌帶,關節和周圍肌肉萎縮並生病。 如果您跳過日常活動來加強受影響的區域,則尤其如此。 關節功能水平下降,不佩戴支具時關節疼痛和不適加劇以及日常活動對支具的依賴程度增加都是支具佩戴時間過長的警告信號。 這些可能成為整個足踝器械市場擴張的障礙。
產品展望
根據產品,足部和腳踝裝置市場細分為支架和支撐,關節植入物,軟組織矯形裝置,矯形固定裝置和假肢。 在 2021 年的足踝器械市場,牙套和護具細分市場實現了大幅增長。 該細分市場的增長歸因於這些設備的優勢。 戴在腳或腳踝周圍的裝置,例如牙套和牙套,通過提供支撐來幫助穩定關節。 扭傷,骨折和肌腱炎等損傷通常使用這些設備進行治療。 此外,如果您有發生足部或腳踝問題的風險,牙套可以幫助您避免受傷。
應用展望
按應用劃分,足踝器械市場可分為錘狀趾,外傷,骨關節炎,類風濕性關節炎,神經病,拇囊炎和骨質疏鬆症。 骨質疏鬆症領域在 2021 年的足踝器械市場實現了顯著的增長。 該細分市場的擴張歸因於大多數骨質疏鬆症患者對支撐裝置的需求不斷增長。 骨質疏鬆症可誘發踝關節骨折,這是一個機械上合理的假設。 廣泛的流行病學研究表明,BMI 較高的男性和女性發生脆性骨折的風險較低,BMD 較高。
區域展望
按地區劃分,分析了北美,歐洲,亞太地區和 LAMEA 的足部和腳踝設備市場。 到 2021 年,北美地區將佔據足踝器械市場的最高收入份額。 大量老年人口的普遍存在以及運動和體力活動相關傷害的高發率是該地區老年人口比例高的主要原因。 根據美國健康排名高級報告,美國約有 5560 萬成年人(約佔人口的 16.9%)年齡在 65 歲或以上。
市場進入者採取的主要策略是產品發布。 根據 Cardinal Matrix 中的分析,DePuy Synthes(Johnson & Johnson)是足部和腳踝設備市場的領先前身。 Enovis Corporation,Stryker Corporation 和 Paragon 28, Inc. 等公司是足踝器械市場的領先創新者。
The Global Foot And Ankle Devices Market size is expected to reach $6.1 billion by 2028, rising at a market growth of 7.1% CAGR during the forecast period.
Many foot and ankle fractures brought on by ailments, including arthritis, diabetes, hammertoes, bunions, and other orthopedic illnesses, can be treated with foot and ankle devices. These medical tools can also replace an amputated or lost foot due to an accident, trauma, congenital abnormality, or any other reason. The foot and ankle devices comprise tools for joint replacement, arthrodesis, and internal fixation treatments that aid in ligament repair and restoration.
These devices assist weak muscles and lessen, stop, or restrict foot and lower leg motion to improve movement patterns. They are also used to maintain joint alignment, adapt deformity, and decrease spasticity. In order to protect the leg and foot, these devices are worn with socks and shoes. Such devices come in several shapes and materials, particularly if they are being developed for children and youngsters, they can be modified for use and growth. Since they are composed of thermoformed plastic, tweaks and changes are possible.
Rheumatoid arthritis (RA) affects roughly one percent of people worldwide, with women being affected at least twice as often as males. More than 23 million people are thought to have RA, according to the World Health Organization. Unfortunately, the way that patients with RA are currently receiving healthcare is not equipped to handle the predicted financial burden of the disease in the coming years. By 2030, the number of RA sufferers could double, according to experts. This will be due to the transition of the baby boom generation between age groups, a greater understanding of RA among professionals, and a somewhat increased incidence of RA is present in people over the age of 70.
Additionally, over 200 million people worldwide are thought to have osteoporosis. Recent data from the International Osteoporosis Foundation show that 1 in 3 women over 50 and 1 in 5 men will sustain an osteoporotic fracture during their lifetimes. Moreover, osteoporosis reduces life expectancy, lengthens lifespan after adjusting for disability, and places a significant financial load on the health insurance systems of the nations in charge of providing care for such individuals. The market for foot and ankle devices is therefore anticipated to expand rapidly.
COVID-19 Impact Analysis
Foot and ankle trauma patients decreased significantly during the pandemic. As a result, the need for foot and ankle devices decreased as hospitals turned their attention to the COVID-19 outbreak. As a result of being unable to focus on routine patients, orthopedics professionals suffered. The treatment of COVID-19 patients required the redeployment of medical personnel. The absence of hospital employees and operating infrastructure slowed market expansion. With constrained supply chains hindering the distribution of these devices and the decrease in treatments worldwide, the COVID-19 pandemic severely impacted the foot and ankle devices market.
Market Growth Factors
Rising foot and ankle issues worldwide
Rheumatoid arthritis, osteoarthritis, and posttraumatic arthritis are the three main kinds of arthritis commonly affecting the foot and ankle. Mobility may be increased using a brace, like an ankle-foot orthosis (AFO). Moreover, using orthotics or specially constructed braces helps lessen pain and reduce pressure on the foot. Compared with standard goods, benefits, including increased efficacy, lower cost, more patient comfort, and convenience of use, are anticipated to increase the demand for these devices and thus benefit the foot and ankle devices market.
Increasing incorporation of technology and strategic initiatives
Patient volume, and surgical expertise, nations like China have also demonstrated vital indicators. The sector for 3D printed orthopedic devices is characterized by the inclusion of individualized prosthetics and metallic implants made of cobalt-chromium alloy, stainless steel, and alpha-beta titanium alloy (Ti-6Al-4V). Therefore, the strategic initiatives by key market participants and the higher acceptance of advanced technologies in the manufacturing of devices are propelling the expansion of the market.
Market Restraining Factors
Severe side effects of foot and ankle devices
Long-term usage of a brace can result in muscular atrophy and deconditioning of the ligaments, joints, and surrounding muscles. This is especially true if daily activities to reinforce the area are skipped. A decline in a joint's functional level, increased pain and discomfort in the joint without the support brace, and greater dependence on the brace for daily activities are all warning indications of wearing a brace for an excessively long time. These could be obstacles to the overall expansion of the foot and ankle devices market.
Product Outlook
Based on product, the foot and ankle devices market is categorized into bracing & support, joint implants, soft tissue orthopedic devices, orthopedic fixation, and prosthetics. The bracing and supporting segment procured a considerable growth rate in the foot and ankle devices market in 2021. The rise of the segment is owed to the benefits of these devices. Devices worn around the foot and ankle, such as braces and supports, help to stabilize the joint by offering support. Injuries, including sprains, fractures, and tendinitis, are frequently treated with them. When a person is at risk of acquiring foot and ankle issues, braces can also be used to avoid injury.
Application Outlook
On the basis of application, the foot and ankle devices market is divided into hammertoe, trauma, osteoarthritis, rheumatoid arthritis, neurological disorders, bunions, and osteoporosis. The osteoporosis segment garnered a remarkable growth rate in the foot and ankle devices market in 2021. Expansion of the segment is owed to the rising demand for support devices in most osteoporosis cases. Osteoporosis could predispose to particular ankle fractures, a mechanically tenable assumption. According to extensive epidemiological research, both men and women with high BMI have lower risks of fragility fractures and greater BMD.
Regional Outlook
Region wise, the foot and ankle devices market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region acquired the highest revenue share in the foot and ankle devices market in 2021. The prevalence of a sizable senior population pool and the high frequency of sports and physical activity-related injuries are the primary causes of this region's big proportion. Almost 55.6 million adults in the US, or roughly 16.9% of the population, are 65 years of age or older, according to America's Health Rankings Senior Report.
The major strategies followed by the market participants are Product Launches. Based on the Analysis presented in the Cardinal matrix; DePuy Synthes (Johnson & Johnson) is the major forerunner in sthe Foot and Ankle Devices Market. Companies such as Enovis Corporation, Stryker Corporation, and Paragon 28, Inc. are some of the key innovators in Foot and Ankle Devices Market.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Stryker Corporation, DePuy Synthes (Johnson & Johnson), Zimmer Biomet Holdings, Inc., Smith & Nephew PLC, Ossur Hf., Enovis Corporation, Acumed LLC (Colson Medical, Inc.), Arthrex, Inc., Paragon 28, Inc. and Orthofix Medical, Inc.
Recent strategies deployed in Foot and Ankle Devices Market
Partnerships, Collaborations, and Agreements:
Jul-2022: Zimmer Biomet signed a three-year agreement with the Hospital for Special Surgery (HSS) for opening the HSS/Zimmer Biomet Innovation Center for Artificial Intelligence (AI) in Robotic Joint Replacement. The companies want to create new decision-support systems, powered by machine learning and data collection, for providing data-driven advice for robotic joint surgery, to surgeons. A team of HSS surgeons and ZB data scientists will work together throughout the agreement to create and test hypotheses that employ data-driven insights to address typical clinical difficulties related to joint replacement. The objective is to inform the creation of algorithms for decision support tools using the validated hypotheses.
Apr-2021: Zimmer Biomet signed a distribution agreement with Device Technologies for the distribution of its surgical product portfolio, with trauma and foot & ankle portfolio, and sports medicine in New Zealand and Australia.
Acquisition and Mergers:
Jan-2023: Zimmer Biomet Holdings signed an agreement to acquire Embody, Inc.., a medical device company engaged in soft tissue healing. The acquisition would broaden Zimmer's portfolio for providing support in the healing of the most difficult orthopedic soft tissue injuries.
Feb-2022: DePuy Synthes completed the acquisition of CrossRoads Extremity Systems, a foot and ankle company that focuses on providing a wide range of procedure-scientific, sterile packed instrumentation and implant systems for lower extremity indications. The acquisition broadened the company's foot and ankle procedure portfolio.
Jan-2022: Stryker is acquiring Vocera Communications, a company engaged in the development of clinical workflow and communication technologies. The acquisition would strengthen Stryker's innovative and highly complementary portfolio of tools, for connecting caregivers and disparate data-generating medical devices, with the aim to improve provider workflow and boost patient safety outcomes.
Jan-2022: Paragon 28, Inc. completed the acquisition of Disior Oy, a three-dimensional analytics pre-operative planning software company focused on complex ankle and foot anatomy. The acquisition accelerated the internal research and development efforts of Paragon and delivers unique pre-operative planning capabilities to surgeons.
Dec-2021: DePuy Synthes acquired OrthoSpin, Ltd., a developer and manufacturer of an automated strut system, a first-of-its-kind technology, which is used together with DePuy Synthes MAXFRAME™ Multi-Axial Correction System, an external ring fixation system. The acquisition enabled DePuy to better serve patients and healthcare professionals at the time of the post-complex surgery recovery period.
Jul-2021: Enovis acquired Mathys AG Bettlach, a company engaged in developing, producing, and distributing implants for artificial joint replacement. The acquisition strengthened DJO's patient-focused portfolio and expanded its reconstructive portfolio.
Jun-2021: Paragon 28 acquired Additive Orthopaedics' product lines including its FDA-approved, first in the world 3D printed Specific Talus Spacer utilized for the treatment of Avascular Necrosis for Humanitarian use. The acquisition provided customers exclusive access to Paragon the only FDA-approved patient-specific total talus replacement implant.
Jan-2021: Smith & Nephew took over Integra LifeSciences Holdings Corporation's Extremity Orthopaedics business. The acquisition assists the former company's strategy of investing in a higher growth strategy and expanding the company's extremities business.
Product Launches and Product Expansions:
Jan-2023: Enovis Corporation unveiled the DynaClip Quattro and DynaClip Delta bone staples, the new addition to Enovis' DynaClip family of bone fixation systems. These staples are pre-loaded on disposable inserters that ease quick deployment and correct leg positioning. Additionally, DynaClip Delta staples are created for offering easier and faster first metatarsophalangeal (MTP) fusion procedures without compromising on performance and durability.
Dec-2022: Stryker unveiled a suture anchor system for ankle and foot procedures, Citrefix. This is a disposable suture anchor system that has a resorbable material anchor body, made with Citregen, an elastomeric material made from a citrate polymer specifically made to mimic bone chemistry for controlled resorption without chronic inflammation.
Nov-2022: Enovis released the DynaNail Helix, a new addition to the DynaNail family and the company's foot and ankle product portfolio. DynaNail Helix is developed for achieving dynamic compression for subtalar fusion with an anatomically, innovative, friendly design, and simple screw-like insertion.
Sep-2022: Stryker introduced the Pulse Intelligent Delivery Platform, a complete circle product, and fulfillment offering developed for high-volume ankle and foot procedures in ambulatory surgery center setups. This platform offers an integrated product delivery and configuration offering for procedures through smart configurations, personalized inventory, and automated services.
Jul-2022: Arthrex unveiled the Arthrex Minimally Invasive Bunionectomy System for providing an alternative solution to traditional bunion surgery. This system is being designed to be an all-inclusive set for facilitating minimally invasive surgical bunion correction. It is clinically proven to get the same or better results as compared to traditional surgery with less swelling, downtime, and pain.
Jun-2022: Enovis announced the release of the Arsenal Ankle Plating System, comprising 37 anatomically designed plates across nine plate families, providing a plating solution for an ankle fracture. The Arsenal Ankle plating System came up with a variable angle locking technology. It allows a cone angulation of 60°, with a multi-lock function, which accepts repeatable lock function and relocking of screw for plate interface. This offers a powerful combination of patented and innovative solutions which would address all fracture personalities.
Apr-2022: Paragon 28, Inc. announced the launch of the R3ACT Stabilization system, a simple solution that helps in multi-stage soft tissue healing after chronic or acute syndesmotic injury to the ankle.
Mar-2022: Acumed launched Ankle Syndesmosis Repair System with Acu-Sinch Knotless technology. Acu-Sinch Knotless Implant allows the dynamic stabilization of laxity or syndesmotic disruptions to the tibiofibular joint. Ankle Syndesmosis Repair System offers the user control to place the medical button subcutaneously without the requirement for direct visualization. Without the necessity for direct visualization, the release mechanism offers the user control to implant the medial button subcutaneously. The Flip Button position may be seen under fluoroscopy because of radiographic indications and the trigger mechanism's tactile feedback. The Acumed and OsteoMed fibula fracture fixation plates as well as intramedullary nails with 3.5 mm nonlocking screw holes can all be used in conjunction with the Acu-Sinch Knotless buttons, either alone or in addition to a washer.
Market Segments covered in the Report:
By Application
By Product
By Geography
Companies Profiled
Unique Offerings from KBV Research
List of Figures